Please assess the completion status of the following clinical trial:

Trial Title: Natera Ovarian Cancer Detection Assay

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Presenting to clinic with adnexal mass suspicious of ovarian, fallopian tube, or peritoneal cancer on imaging~* Must be planning surgical resection or biopsy~* Must be treatment naïve~* Must be 18 years or older~* Able to understand and sign a written informed consent document~* Able to provide 40mL of blood (at least 20mL) for each blood draw~Exclusion Criteria:~* Prior removal of either ovary for any reason~* Currently pregnant~* Blood transfusion within 3 months of study enrollment~* History of bone marrow or organ transplant~* Prior history and treatment for any malignancy, with exception of previously treated non-melanoma skin cancer.~* A medical condition that would place subject at risk as a result of the blood donation, including but not limited to bleeding disorders, chronic infectious disease, emphysema or serious anemia

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).